Blood. 2021 Mar 25;137(12):1565-1567. doi: 10.1182/blood.2020010544.
PMID:33764434
Pure erythroid leukemia.
Wang W, Wang SA, Medeiros LJ, Khoury JD.
Am J Hematol. 2017 Mar;92(3):292-296. doi: 10.1002/ajh.24626. Epub 2017 Feb 3.
PMID:28006859
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM, Heerema-McKenney AE, Choi JK, Smith J, Ries RE, Hirsch BA, Raimondi SC, Alonzo TA, Wang YC, Aplenc R, Sung L, Gamis AS, Meshinchi S, Kahwash SB.
Blood Adv. 2020 Dec 8;4(23):6000-6008. doi: 10.1182/bloodadvances.2020002712.
PMID:33284945
Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
Reichard KK, Tefferi A, Abdelmagid M, Orazi A, Alexandres C, Haack J, Greipp PT.
Blood Cancer J. 2022 Nov 2;12(11):147. doi: 10.1038/s41408-022-00746-x.
PMID:36323674
HDAC7 is a potential therapeutic target in acute erythroid leukemia.
Zhang W, Yamamoto K, Chang YH, Yabushita T, Hao Y, Shimura R, Nakahara J, Shikata S, Iida K, Chen Q, Zhang X, Kitamura T, Goyama S.